Engineered porcine epidermal repair substance (rEGF) is gaining increased recognition as a key strategy in the domain of tissue medicine. This active compound, created through recombinant technology, offers a https://recombinant-porcine-egf438429.designi1.com/63718621/synthetic-swine-cutaneous-growth-factor-a-effective-agent-for-wound-regeneration